CLINICAL VIEW ON SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS IN A MEDICALLY SUPERVISED INJECTING ROOM: A DECADE OF EXPERIENCE

Authors

  • Raul F. Palma-Álvarez Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Constanza Daigre Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Thais Ballabriga- Córdoba Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain.
  • Elisabet Monterde-Ochoa Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain.
  • Miriam Sierra-Fortuny Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain.
  • Miguel Cantillo Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain.
  • Manuel Pelae Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain.
  • Eduardo Castrillo Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain.
  • Laura Camañes Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain.
  • Carlos Roncero Psychiatry Service, University of Salamanca Health Care Complex, Insitute of Biomedicine, Salamanca, Spain; Psychiatry Unit, School of Medicine, University of Salamanca, Salamanca, Spain.
  • Josep A. Ramos-Quiroga Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Lara Grau-López1 Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.

Keywords:

Harm reduction, Medically supervised injecting center, People who inject drugs, Psychosis, Substance-induced psychosis, Substance use disorder

Abstract

Introduction. Medically supervised injecting rooms (MSIRs) are extremely important facilities for people who inject drugs (PWID) as MSIRs provide a safe place for the consumption of street-sourced drugs, impacting overdose rates and viral transmitted infections.

Methods. The current paper describes more than 10 years of our MSIR experience regarding psychotic symptoms and their relationship with the substance used. The analysis was performed using data collected between 01/01/2009 and 08/31/2021.

Results. 3731 self-injections (68.7% heroin, 29.1% cocaine, 2.1% speedball, and 0.2% other substance) were recorded during the studied period. Psychotic symptoms were only observed in 7.1% of the total self-injections.

However, large differences were detected among substances: 23.2% of cocaine consumptions were related to psychotic symptoms, 20.8% of speedball injections presented psychotic symptoms, and only 0.3% of heroin consumptions had psychotic symptoms (X2 =604.99; p<0.001). Also, some other variables highlight that psychotic symptoms induced by substances may be associated with higher clinical severity.

Conclusions. subjects with cocaine or speedball use who attend MSIRs may present substance-induced psychotic symptoms, having higher clinical severity. Thus, MSIRs’ protocols should be analyzed and adapted in terms of the substance used and the induction of psychotic symptoms. Moreover, further research is necessary on this critical issue.

Published

2023-07-01

How to Cite

Raul F. Palma-Álvarez, et al. “CLINICAL VIEW ON SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS IN A MEDICALLY SUPERVISED INJECTING ROOM: A DECADE OF EXPERIENCE”. Actas Españolas De Psiquiatría, vol. 51, no. 4, July 2023, pp. 188-91, https://actaspsiquiatria.es/index.php/actas/article/view/49.

Issue

Section

Letter to Editor